{"id":10880,"date":"2026-02-03T14:31:08","date_gmt":"2026-02-03T14:31:08","guid":{"rendered":"https:\/\/palynziqpatient-prod-001.azurewebsites.net\/en-us\/?page_id=10880"},"modified":"2026-04-23T15:41:14","modified_gmt":"2026-04-23T15:41:14","slug":"teens","status":"publish","type":"page","link":"https:\/\/palynziq.biomarin.com\/en-us\/study-results\/teens\/","title":{"rendered":"Results with teens"},"content":{"rendered":"
In an ongoing study of teens ages 12\u201317 with PKU, initial Phe levels averaged about 17 mg\/dL.<\/p>\n <\/div>\n\n
Exploratory data from the ongoing study<\/strong><\/p>\n By a data cutoff in October 2025, most teens* had taken PALYNZIQ injection\u2028for an average of 28 months, and:<\/p>\n <\/div>\n\n This was an exploratory outcome from the clinical trial. Results may vary. Please talk to your healthcare provider if you have any questions.<\/p>\n<\/figcaption>\n <\/figure>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n *This only includes teens in the study who were originally randomized to take PALYNZIQ. I definitely feel more confident, because I feel more in charge of my life.<\/p>\n <\/div>\n
\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n <\/div>\n
\n<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
<\/div>\n\n